智通财经APP讯，希玛医疗(03309)发布公告，预期截至2025年12月31日止年度(2025财政年度)本公司将实现转亏为盈，使本公司股东应占利润达9000万港元至1.1亿港元之间，而截至2024年12月31日止年度(2024财政年度)则取得股东应占亏损1.35亿港元。
预期本公司股东应占利润将有所增加，主要受以下因素所带动：收益由2024 财政年度的19.13亿港元轻微增加至2025财政年度的约19.47亿港元;我们优化服务网络及提升营运效率的策略成效显著，包括关闭表现欠佳的业务;及2025财政年度并未就非流动资产取得重大减值亏损，而2024财政年度则取得减值亏损1.98亿港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.